Information Bank Details

Anti-Thymocyte Globulin (ATG) for Aplastic Anemia

Location
Stored in secure location subject to Ontario Health Internal Data Access Request process.
Authority
Connecting Care Act, 2019
Personal Information Maintained

Health card number, Postal code, Dosage amounts

Disclosure
Not available
Uses
To conduct reimbursements of ATG drugs for Aplastic Anemia patients and to fulfill Ontario Health mandate.
Users
Ontario Health Internal Program Teams, Acute Leukemia Service Sites, CMH Advisory Committees and Steering Committees, and CMH Executive Sponsors.
Individuals in the Bank

Anti-Thymocyte Globulin (ATG) for Aplastic Anemia Patients

Retention and Disposal
50 years from the last date of access in accordance with Records Series 900. Data is destroyed following the Media and Data Destruction, Sanitization and Disposal Standard.

Last Updated: June 23, 2025